Stocks closed modestly lower in a volatile session as market participants weighed better U.S. economic data against the fears the Fed may soon start to curtail its bond buying.» Read More
Stocks advanced, buoyed by a sharp drop in oil prices, but technology stocks dragged on the market after disappointing earnings from Apple and Texas Instruments.
The average bear market shows a decline of 30%, but then has an average 30% plus bounce when the bottom is reached. We are off more than 20% so it's possible the end is in sight.
Asian stocks outside of Japan slipped Tuesday after a landslide of lower-than-expected U.S. corporate results sparked fears of a pullback in consumer demand, boding ill for the region's exporters. But Tokyo rallied 3% higher.
Cramer lays out his plan for playing this key shift in the markets.
With so much news Monday we need two "Word on the Street" posts. Find out what the traders are saying about oil, the financials and more!
Stocks slipped as the bank rally that has stretched four sessions appeared to run out of steam ahead of Wachovia's report. Merck fell following disappointing results from a cholesterol-drug study.
Stocks slipped as the morning bank rally fizzled. Merck fell following disappointing results from a cholesterol-drug study.
Stocks slipped as the bank rally that has stretched four sessions appeared to fizzle ahead of Wachovia's report. Merck fell following disappointing results from a cholesterol-drug study.
The recent spate of takeovers, particularly in pharmaceuticals, represents the first step in what analysts expect to be a busier second half of the year for mergers and acquisitions.
Skeptics correctly point out that last week's trifecta of news (bank earnings above expectations, new limitations on naked short selling for select financials, and the Fed/Treasury helping out Fannies/Freddie), primarily benefited financials. What's changed for everyone else since then, skeptics ask? Not much.
The dollar slipped on Monday, losing some of its recent momentum, after better-than-expected earnings from Bank of America failed to convince investors that the worst for the U.S. financial sector is over.
Gains in financial stocks lifted European shares on Monday as markets cheered Bank of America's stronger-than-expected quarterly results, while declines in Roche offset some of the gains.
Stocks advanced, led by a fourth straight rally in bank stocks after Bank of America beat expectations. News of a potential pharma deal also gave the market a boost.
Bank of America's quarterly profit fell less than expected despite a surge in bad loans, causing shares of the largest U.S. retail bank and mortgage lender to soar.
Bank of America made it four in a row with big banks beating expectations, and beating big: $0.72 is 40 percent higher than the $0.53 expected. Revenues were a knockout as well: $20.32 billion, 10 percent above the estimate of $18.37 billion.
Wells Fargo handed in some good results, but watch for trouble out of Wachovia.
European stocks were set to inch higher on Monday, extending a three-session rally, as investors brace for a flurry of corporate earnings from U.S. bellwethers such as Apple , Merck and Bank of America.
Stocks are casting a wary eye on oil and, lacking any dramatic events, earnings news could steer the market.
Volatility reigned as the Dow closed below 11,000 for the first time since July, 2006 on Tuesday, followed by a market rally and the biggest 3-day gain of the Dow since March, 2003.
Stocks turned mixed Friday as banks rebounded and Google and Microsoft slammed techs.